Skip to main content

Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Table 1 Cell Viability

From: A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols

Viability (%) Donor Mean Median < 70% 70-100%
  1 84.7 86.2 3 (15%) 17 (85%)
  2 88.5 90.5 1 (5%) 19 (95%)
  3 86.3 86.1 0 (0%) 20 (100%)
  4 85.0 87.2 2 (10%) 18 (90%)
  1. The table reports the overall viability for each of the thawed PBMC donor samples as determined by trypan blue staining. The table presents the mean and median viability for each donor. It also reports the proportion within optimal and suboptimal ranges.